Sunday, August 31, 2014 5:53:56 AM
http://www.wkrb13.com/markets/365383/nanoviricides-sees-significant-growth-in-short-interest-nnvc/
As an investor, I generally like to be going in when others have already established a large short position. I say generally because there is proper timing and other considerations. But I recognize that when shorts position incorrectly, they often create an upside spike when trying to cover (short squeeze). The article is dated 8/29/2014 (last Friday), and states that 9.8 percent of shares are sold short, with 9.7 days to cover.
I am not a short interest expert, but 9.8% of a company with a low float, and 9.7 days to cover could be very problematic for shorts if events turn on them and they need to cover. Very good news for longs.
I recently started a trade position at $3.87. I've been watching the trade, and I liked what I was seeing on Friday (29th). Whenever I start a new position, I keep a tight stop just in case. But, I am enticed by the low stochastics (8.61), and the price being at the lower Bollinger band level. I also thought for the Friday before the Labor Day weekend volume looked pretty good.
Friday's trade was a little volatile, $3.85 to $3.98 back down to $3.85 before closing at $3.92, with an afterhours trade at $4.00.
Still a little cautious here, but may be worth keeping an eye on.
I am anticipating news this month.
A little dated, but here is the link to the IAIR interview of Dr. Diwan. He's asked good questions. Check it out:
http://www.iaireview.org/scheda_video.php?id=28
Just my opinion, Dr.Diwan comes across as one smart cookie:
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM